Voyager Therapeut (VYGR)

$5.82 0.28 (5.05%)

15:18 EST VYGR Stock Quote Delayed 30 Minutes

Louis Navellier and the InvestorPlace Research Staff

7 Top-Rated Biotech Stocks to Buy for Q4

By Louis Navellier and the InvestorPlace Research Staff Sep 15, 2022

A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

VYGR Stock: The Huge Licensing Deal Sending Voyager Therapeutics Rocketing Higher

7 Stocks for Value Investors to Buy Near Their 52-Week Lows

More Articles

Volume:

Previous Close -

Market Cap 224.69M

PE Ratio -12.65

EPS -0.46

Volume (Avg. Vol.) 55,577

Day's Range $5.49 - $5.87

52-Week Range $2.54 - $10.60

Dividend & Yield N/A (N/A)

VYGR Stock Predictions, Articles, and Voyager Therapeut News

From InvestorPlace
From the Web

10 High-Growth Stocks Every Young Investor Should Own

By Josh Enomoto, InvestorPlace Contributor Sep 3, 2020

Young investors can leverage their extra time to bet on high-growth stocks that are likely to jump on developing trends.

3 Top Gene Therapy Stocks That Could Soar

By Aaron Levitt, InvestorPlace Contributor May 30, 2019

Biotech stocks targeting gene therapy are going to be huge. Here are 3 gene therapy stocks to buy that have a ton of potential.

7 Cheap Biotech Stocks to Buy Now

By Anthony Mirhaydari, InvestorPlace Market Strategist Aug 23, 2018

These biotech stocks are set for a strong comeback as investors start to walk away from large-cap tech companies. Here's what investors need to know about each company.

7 Strong Buy Stocks Analysts Are Upgrading Now, Including Facebook, Inc.

By Harriet Lefton, Writer, TipRanks Jun 13, 2018

Here we dig down into seven intriguing stock rating upgrades from the Street. Why now? Why are analysts turning bullish on these stocks? All seven of these stocks share a 'Strong Buy' analyst consensus rating from the Street. The result: you can be confident that these stocks are the crème de la crème.

3 Stocks to Watch on Tuesday: Mondelez International Inc (MDLZ), SBA Communications Corporation (SBAC) and Voyager Therapeutics Inc (VYGR)

By Karl Utermohlen, InvestorPlace Writer Oct 31, 2017

Mondelez (MDLZ) and SBA Communications (SBAC) posted earnings, while Voyager Therapeutics (VYGR) issued an update on its Parkinson's drug.

BTIG Sticks to Their Hold Rating for Voyager Therapeutics (VYGR)

From TipRanks Nov 10, 2022

In a report released on November 8, Yun Zhong from BTIG maintained a Hold rating on Voyager Therapeutics (VYGR – Research Report). The company’s shares ...

Robert W. Baird Sticks to Its Buy Rating for Voyager Therapeutics (VYGR)

From TipRanks Nov 10, 2022

In a report released on November 8, Jack Allen from Robert W. Baird maintained a Buy rating on Voyager Therapeutics (VYGR – Research Report), with a price tar...

Voyager Therapeutics' TRACER Capsids Show Encouraging Action In Animal Models

From Benzinga May 19, 2022

The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate

From Benzinga May 19, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

83 Biggest Movers From Yesterday

From Benzinga May 6, 2022

Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.

Recap: Voyager Therapeutics Q4 Earnings

From Benzinga Mar 8, 2022

Voyager Therapeutics (NASDAQ:VYGR) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:15 AM. Here's what investors need to know about the announcement....